Related references
Note: Only part of the references are listed.Thrombin Generation Assay and Its Application in the Clinical Laboratory
Armando Tripodi
CLINICAL CHEMISTRY (2016)
Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation
Molly H. Thompson et al.
JOURNAL OF CLINICAL ANESTHESIA (2016)
Genetic Determinants of Thrombin Generation and Their Relation to Venous Thrombosis: Results from the GAIT-2 Project
Laura Martin-Fernandez et al.
PLOS ONE (2016)
Thrombin generation: biochemical possibilities and clinical reality
H. Coenraad Hemker
BLOOD (2015)
Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test
Sophie Mathieu et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
Thrombin generation and international normalized ratio in inherited thrombophilia patients receiving thromboprophylactic therapy
Hilda Luna-Zaizar et al.
THROMBOSIS RESEARCH (2015)
Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis
Karin C. A. A. Wildhagen et al.
BLOOD (2014)
Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
Clifford M. Takemoto et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation
Saartje Bloemen et al.
HAEMATOLOGICA (2013)
Thrombin generation in clinical conditions
Hugo ten Cate
THROMBOSIS RESEARCH (2012)
Early diagnosis of venous thrombosis by means of venography and abortive treatment with heparin
GUNNAR BAUER
ACTA MEDICA SCANDINAVICA (2010)
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery
Yesim Dargaud et al.
BLOOD (2010)
Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery
Ravi Taneja et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2009)
Lessons learned from the contamination of heparin
Haiying Liu et al.
NATURAL PRODUCT REPORTS (2009)
Intraindividual thrombin generation measurement variability in healthy adults over a one year period
Yesim Dargaud et al.
THROMBOSIS RESEARCH (2009)
The story of the discovery of heparin and warfarin
Douglas Wardrop et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Linear diffusion of thrombin and factor Xa along the heparin molecule explains the effects of extended heparin chain lengths
Rob Wagenvoord et al.
THROMBOSIS RESEARCH (2008)
Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
R Al Dieri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision
Y Dargaud et al.
HAEMOPHILIA (2005)
Low-dose heparin to low molecular weight heparin prophylaxis: in pursuit of excellence - a personal perspective
VV Kakkar
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time
R Al Dieri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Comparing methods of establishing the aPTT therapeutic range of heparin
CI Liepman et al.
ANNALS OF PHARMACOTHERAPY (2003)
The inhibition of blood coagulation by heparins of different molecular weight is caused by a common functional motif -: the C-domain
R Al Dieri et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Share Paper
